Neurotransmitter Actions and Interactions: Proceedings of a Satellite Symposium of the 12th International Society for Neurochemistry Meeting, Algarve, Portugal, April 29–30, 1989

Front Matter....Pages I-X
Theodore Lionel Sourkes: an appreciation....Pages 1-3
Reflections at seventy....Pages 5-12
The psychopharmacology of GABA synapses: update 1989....Pages 13-28
Formation of 12-lipoxygenase metabolites in rat cerebral cortical slices: stimulation by calcium ionophore, glutamate and N-methyl-D-aspartate....Pages 29-37
Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology. An integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes....Pages 39-48
Neurochemical approaches to the amelioration of brain injury....Pages 49-56
Neuronal nicotinic α-bungarotoxin receptors....Pages 57-64
Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies....Pages 65-75
Peptide regulation of adrenal medullary function....Pages 77-89
Inborn errors of carnosine and homocarnosine metabolism....Pages 91-106
Histamine inactivation in the brain: aspects of N-methylation....Pages 107-118
Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission....Pages 119-129
Biological model for the in vivo measurement of rate of serotonin synthesis in the brain....Pages 131-140
Cerebral serotonin in viral encephalitis....Pages 141-151
Retinal neurotransmitter interaction as reflected in horizontal cell spatial behaviour....Pages 153-162
Phenolsulfotransferase (PST) and PAPS in catecholamine metabolism in human tissues: an overview....Pages 163-171
Effect of some peptides on dopaminergic function in man....Pages 173-181
Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine....Pages 183-193
Investigations on auto-antibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures....Pages 195-206
Implantable microencapsulated dopamine (DA): prolonged functional release of DA in denervated striatal tissue....Pages 207-215
Partial damage to nigrostriatal bundle: compensatory changes and the action of L-DOPA....Pages 217-232
MAO and L-DOPA treatment of Parkinson’s disease....Pages 233-239
Oxidative stress: a role in the pathogenesis of Parkinson’s disease....Pages 241-249
Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson’s disease may depend on iron-melanin interaction....Pages 251-258
The effects of aging on MAO activity and amino acid levels in rat brain....Pages 259-268
The interactions of monoamine oxidase with some derivatives of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)....Pages 269-277
From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors....Pages 279-292
Back Matter....Pages 293-309